AICX協会と医師が医療ヘルスケアAIプロジェクトを発足

AIエージェントの社会実装を通じ、人とAIが共に創る新たな顧客体験の実現を目指す一般社団法人AICX協会と、デジタルヘルス分野のサービス開発からプラットフォーム提供までを総合的に支援する株式会社ドクターズは、このたびパートナーシップを締結し、新たな医療ヘルスケアAIエコシステムの創出に向けた共創プロジェクトを開始したことをお知らせいたします。.

The “Healthcare ONE™ / AICX PROJECTS,” launched under this partnership, is a co-creation project aimed at connecting the use of AI in the medical and healthcare fields to actual medical settings, businesses, and society, rather than remaining limited to concept and demonstration. With a medical and healthcare platform at its core, the project aims to realize next-generation “AI Connected Care” by organically connecting medical institutions, doctors, AI technology, companies, and consumers, and integrating previously fragmented medical and health data and experiences.

現在 先生方 and other medical professionals is increasing year by year, and in order to maintain and improve the health of the nation’s citizens, a fundamental review of the work processes related to diagnosis, treatment, and operation at medical institutions is required.

- 広告

こちらもお読みください： Ubieと亀田病院がAI肥満治療のPoCを開始

At the same time, in the environment surrounding patients and general users, the amount of medical and health-related information is rapidly increasing and becoming more dispersed, making it difficult to properly integrate and combine this information and use it to make decisions and take action appropriate to each individual’s situation.To support the health of not only medical professionals but also patients and individuals, there is a strong demand for the development of an environment that organizes and utilizes reliable information and supports appropriate decision-making.

これらの課題に対処するために AICX協会, AIエージェントやAIの標準化・ガバナンスの分野をリードしてきた株式会社ドクターズと、医療・ヘルスケアプラットフォームを通じて医療分野のデジタルトランスフォーメーションを推進してきた株式会社ドクターズは、医療ヘルスケアAIの社会実装を視野に入れた新たな共創プロジェクトを立ち上げました。.

33の医療機関で実証、そして米国へ

Doctors Station® AIは、医療機関や医師ネットワーク、医療データインフラと連携し、医療現場に特化したAIサービスの設計・開発・検証を可能にするプラットフォームです。.

Doctors will provide 33 medical institutions both in Japan and overseas as testing and verification sites for this project, refining its AI services in actual medical settings. These medical institutions include clinics not only in Japan but also in the United States, making it possible to implement medical healthcare AI in society with an eye toward global expansion. By assuming testing in real medical settings, the company will create “AI that is used,” “AI that will continue to exist,” and “AI that will spread.”

ソース PRタイムズ